IDEAYA Biosciences (IDYA) EBT Margin (2020 - 2025)
Historic EBT Margin for IDEAYA Biosciences (IDYA) over the last 6 years, with Q4 2025 value amounting to 869.53%.
- IDEAYA Biosciences' EBT Margin rose 11895900.0% to 869.53% in Q4 2025 from the same period last year, while for Dec 2025 it was 90.14%, marking a year-over-year increase of 45809300.0%. This contributed to the annual value of 72.84% for FY2025, which is 45982300.0% up from last year.
- According to the latest figures from Q4 2025, IDEAYA Biosciences' EBT Margin is 869.53%, which was up 11895900.0% from 52.18% recorded in Q3 2025.
- In the past 5 years, IDEAYA Biosciences' EBT Margin registered a high of 52.18% during Q3 2025, and its lowest value of 2059.11% during Q4 2024.
- Moreover, its 5-year median value for EBT Margin was 384.53% (2022), whereas its average is 519.11%.
- As far as peak fluctuations go, IDEAYA Biosciences' EBT Margin tumbled by -9903500bps in 2024, and later surged by 11895900bps in 2025.
- Quarter analysis of 5 years shows IDEAYA Biosciences' EBT Margin stood at 620.16% in 2021, then fell by -6bps to 657.46% in 2022, then crashed by -63bps to 1068.77% in 2023, then tumbled by -93bps to 2059.11% in 2024, then surged by 58bps to 869.53% in 2025.
- Its EBT Margin stands at 869.53% for Q4 2025, versus 52.18% for Q3 2025 and 2059.11% for Q4 2024.